BlairMcNamaraMD

Gynecologic Oncology

Fellow Yale New Haven Hospital

Dr. McNamara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
20 York St
New Haven, CT 06510
Phone+1 203-785-5188

Fax+1 203-785-5163

University of California (San Francisco)Residency, Obstetrics and Gynecology, 2018 - 2022
Yale School of MedicineClass of 2018

PubMed

6 citations
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
Justin Harold, Stefania Bellone, Diego D Manavella, Levent Mutlu, Blair McNamara
Gynecologic Oncology. 2023-01-01
4 citations
Antibody-Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors.
Blair McNamara, Michelle Greenman, Nicole Pebley, Levent Mutlu, Alessandro D Santin
Molecules. 2023-11-02
3 citations
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich
Gynecologic Oncology. 2023-02-01